GL1X · GenesisL1 explorer

Research workbench

Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor VBY-825 (Partial Occupancy)

Analyse Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7MNG
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.7
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
ZL7
Pockets
3 · best druggability 0.55

Structure

x-ray diffraction · resolution 1.7 · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30626% helix, 29% strandP0DTD1

Ligands and binding sites

  • ZL7 · (2R,3S)-N-cyclopropyl-3-{[(2R)-3-(cyclopropylmethanesulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanoyl]amino}-2-hydroxypentanamide (non-preferred name) · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 8 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1800.550.8616DMS
22280.530.7727ZL7, DMS
3600.310.7613empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7MNG · Crystal structure of SARS-cov-2 main protease (3CLPRO/MPRO) in complex with covalent… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.